Positron emission tomography (PET) represents the most advanced scintigraph
ic imaging technology. It can be employed for cardiovascular research as we
ll as for clinical applications in patients with various cardiovascular dis
eases. PET allows the noninvasive functional assessment of myocardial perfu
sion, substrate metabolism and cardiac innervation as well as the study of
skeletal muscle metabolism and perfusion in vivo. The large number of exist
ing tracers and the flexibility of the PET technique that allows it to be c
ombined with many other methods, such as the insulin clamp technique, incre
ase its potential as a research tool. In the detection of myocardial viabil
ity PET is regarded as re golden standard, and it is the only method availa
ble for the quantitative assessment of myocardial blood flow.